These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32202249)

  • 1. Is sickle cell disease-related neurotoxicity a systemic endotheliopathy?
    Palomo M; Diaz-Ricart M; Carreras E
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):111-115. PubMed ID: 32202249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction.
    Nader E; Conran N; Romana M; Connes P
    Compr Physiol; 2021 Apr; 11(2):1785-1803. PubMed ID: 33792905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular pathophysiology of sickle cell disease.
    Connes P; Renoux C; Joly P; Nader E
    Presse Med; 2023 Dec; 52(4):104202. PubMed ID: 37944640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophils as drivers of vascular injury in sickle cell disease.
    Torres LS; Hidalgo A
    Immunol Rev; 2023 Mar; 314(1):302-312. PubMed ID: 36251624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboinflammatory mechanisms in sickle cell disease - challenging the hemostatic balance.
    Conran N; De Paula EV
    Haematologica; 2020 Oct; 105(10):2380-2390. PubMed ID: 33054078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic nervous system involvement in sickle cell disease.
    Coates TD; Chalacheva P; Zeltzer L; Khoo MCK
    Clin Hemorheol Microcirc; 2018; 68(2-3):251-262. PubMed ID: 29614636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle Cell Disease and Thromboembolism: New Insights on the Pathophysiology, Diagnosis, and Treatment.
    Dobie G
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of Sickle Cell Disease.
    Sundd P; Gladwin MT; Novelli EM
    Annu Rev Pathol; 2019 Jan; 14():263-292. PubMed ID: 30332562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidics for investigating vaso-occlusions in sickle cell disease.
    Horton RE
    Microcirculation; 2017 Jul; 24(5):. PubMed ID: 28376286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism.
    Hamali HA
    Hemoglobin; 2023 Nov; 47(6):205-214. PubMed ID: 38189099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell disease, vasculopathy, and therapeutics.
    Kassim AA; DeBaun MR
    Annu Rev Med; 2013; 64():451-66. PubMed ID: 23190149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement involvement in sickle cell disease.
    Meuleman MS; Roumenina LT; Grunenwald A
    Presse Med; 2023 Dec; 52(4):104205. PubMed ID: 37972851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease.
    Li H; Kazmi JS; Lee S; Zhang D; Gao X; Maryanovich M; Torres L; Verma D; Kelly L; Ginzburg YZ; Frenette PS; Manwani D
    Blood; 2023 Jan; 141(2):194-199. PubMed ID: 36315910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
    PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of musculoskeletal manifestations in sickle cell disease patients.
    Kosaraju V; Harwani A; Partovi S; Bhojwani N; Garg V; Ayyappan S; Kosmas C; Robbin M
    Br J Radiol; 2017 May; 90(1073):20160130. PubMed ID: 28281830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting ICAM1 to Ameliorate Vaso-Occlusion and Inflammation in Sickle Cell Disease.
    Gupta P; Kumar R
    Eur J Haematol; 2024 Dec; 113(6):730-737. PubMed ID: 39354752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation in sickle cell disease.
    Conran N; Belcher JD
    Clin Hemorheol Microcirc; 2018; 68(2-3):263-299. PubMed ID: 29614637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin in renal injury due to sickle cell disease.
    Tharaux PL
    Contrib Nephrol; 2011; 172():185-199. PubMed ID: 21893999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Featured Article: Depletion of HDL
    Soupene E; Larkin SK; Kuypers FA
    Exp Biol Med (Maywood); 2017 Jun; 242(12):1244-1253. PubMed ID: 28436274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between coagulation and vascular inflammation in sickle cell disease.
    Sparkenbaugh E; Pawlinski R
    Br J Haematol; 2013 Jul; 162(1):3-14. PubMed ID: 23593937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.